These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28549444)

  • 21. Clinicopathological features and endoscopic findings of HER2-positive gastric cancer.
    Oono Y; Kuwata T; Takashima K; Yoda Y; Ikematsu H; Shitara K; Kinoshita T; Yano T
    Surg Endosc; 2018 Sep; 32(9):3964-3971. PubMed ID: 29500656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratumoral heterogeneity determines discordant results of diagnostic tests for human epidermal growth factor receptor (HER) 2 in gastric cancer specimens.
    Yang J; Luo H; Li Y; Li J; Cai Z; Su X; Dai D; Du W; Chen T; Chen M
    Cell Biochem Biophys; 2012 Jan; 62(1):221-8. PubMed ID: 21927816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [HER2 and gastric cancer. Recommendations for clinical practice in 2011].
    Penault-Llorca F; Chenard MP; Bouché O; Emile JF; Bibeau F; Metges JP; André T; Monges G
    Ann Pathol; 2011 Apr; 31(2):78-87. PubMed ID: 21601111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratumoral and intertumoral heterogeneity of HER2 immunohistochemical expression in gastric cancer.
    Zhang H; Wang Y; Wang Y; Wu D; Lin E; Xia Q
    Pathol Res Pract; 2020 Nov; 216(11):153229. PubMed ID: 33010699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer.
    Yano T; Doi T; Ohtsu A; Boku N; Hashizume K; Nakanishi M; Ochiai A
    Oncol Rep; 2006 Jan; 15(1):65-71. PubMed ID: 16328035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in HER2 over-expression between proximal and distal gastric cancers in the Chinese population.
    Fan XS; Chen JY; Li CF; Zhang YF; Meng FQ; Wu HY; Feng AN; Huang Q
    World J Gastroenterol; 2013 Jun; 19(21):3316-23. PubMed ID: 23745034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types.
    Fujimoto M; Matsuzaki I; Nishino M; Iwahashi Y; Warigaya K; Kojima F; Ono K; Murata SI
    J Clin Pathol; 2018 Jul; 71(7):600-607. PubMed ID: 29305518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HER2 assessment in locally advanced gastric cancer: comparing the results obtained with the use of two primary tumour blocks versus those obtained with the use of all primary tumour blocks.
    Xu C; Liu Y; Jiang D; Ge X; Zhang Y; Su J; Zeng H; Huang J; Ji Y; Hou J; Sun Y; Shen K; Liu T; Hou Y; Qin J
    Histopathology; 2017 Oct; 71(4):570-579. PubMed ID: 28513868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of accurate human epidermal growth factor receptor-2 (HER2) evaluation as a new biomarker in gastric cancer.
    Kimura Y; Oki E; Yoshida A; Aishima S; Zaitsu Y; Ohtsu H; Ando K; Ida S; Saeki H; Morita M; Kusumoto T; Oda Y; Maehara Y
    Anticancer Res; 2014 Aug; 34(8):4207-12. PubMed ID: 25075048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor Heterogeneity Index to Detect Human Epidermal Growth Factor Receptor 2 Amplification by Next-Generation Sequencing: A Direct Comparison Study with Immunohistochemistry.
    Choi S; Chu J; Kim B; Ha SY; Kim ST; Lee J; Kang WK; Han H; Sohn I; Kim KM
    J Mol Diagn; 2019 Jul; 21(4):612-622. PubMed ID: 31022472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human epidermal growth factor receptor 2 testing in gastric carcinoma: issues related to heterogeneity in biopsies and resections.
    Lee S; de Boer WB; Fermoyle S; Platten M; Kumarasinghe MP
    Histopathology; 2011 Nov; 59(5):832-40. PubMed ID: 22092394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concordance of HER2 Immunohistochemistry and Fluorescence
    Furrer D; Jacob S; Caron C; Sanschagrin F; Provencher L; Diorio C
    Anticancer Res; 2017 Jun; 37(6):3323-3329. PubMed ID: 28551685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors.
    Zhang L; Qiu M; Jin Y; Ji J; Li B; Wang X; Yan S; Xu R; Yang D
    Int J Clin Exp Pathol; 2015; 8(9):11084-91. PubMed ID: 26617827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HER2 immunohistochemistry significantly overestimates HER2 amplification in uterine papillary serous carcinomas.
    Mentrikoski MJ; Stoler MH
    Am J Surg Pathol; 2014 Jun; 38(6):844-51. PubMed ID: 24698965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HER2 in resected gastric cancer: Is there prognostic value?
    Fisher SB; Fisher KE; Squires MH; Patel SH; Kooby DA; El-Rayes BF; Cardona K; Russell MC; Staley CA; Farris AB; Maithel SK
    J Surg Oncol; 2014 Feb; 109(2):61-6. PubMed ID: 24122802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101).
    Matsusaka S; Nashimoto A; Nishikawa K; Miki A; Miwa H; Yamaguchi K; Yoshikawa T; Ochiai A; Morita S; Sano T; Kodera Y; Kakeji Y; Sakamoto J; Saji S; Yoshida K
    Gastric Cancer; 2016 Jul; 19(3):839-51. PubMed ID: 26265390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunohistochemical assessment of HER2 expression in gastric cancer. A clinicopathologic study of 93 cases].
    Alvarado-Cabrero I; Gil-Hernández S; Ruelas-Perea A; Villaverde-Rodríguez D; Montes-Ochoa JR; Medrano-Guzmán R
    Cir Cir; 2017; 85(6):504-509. PubMed ID: 28069112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Her-2/neu assessment for gastric carcinoma: validation of scoring system.
    Mrklic I; Bendic A; Kunac N; Bezic J; Forempoher G; Durdov MG; Karaman I; Prusac IK; Pisac VP; Vilovic K; Tomic S
    Hepatogastroenterology; 2012; 59(113):300-3. PubMed ID: 22260838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative study of the determination of the HER2 status in gastric cancer in the biopsy and intraoperative specimens].
    Zavalishina LÉ; Andreeva II; Vinogradov II; Danilova NV; Kuznetsova OA; Frank GA
    Arkh Patol; 2014; 76(6):22-27. PubMed ID: 25842922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of intratumoral heterogeneity of HER2 expression between primary tumor and multiple organ metastases in gastric cancer: Clinicopathological study of three autopsy cases and one resected case.
    Saito T; Kondo C; Shitara K; Ito Y; Saito N; Ikehara Y; Yatabe Y; Yamamichi K; Tanaka H; Nakanishi H
    Pathol Int; 2015 Jun; 65(6):309-17. PubMed ID: 25828363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.